Kelly Walsh

Kelly Walsh is a Senior Scientist I at Oxford Biomedica, having progressed through the ranks from Scientist I to Scientist II since joining in March 2022. Prior experience includes roles as Scientist I at Homology Medicines, Inc. and Associate Scientist III as well as Engineer I at Biogen, focusing on protein pharmaceutical development. Earlier career positions include Associate Scientist II at Mersana Therapeutics and Senior Research Associate at Axcella, alongside graduate research at Boston University under the guidance of Sean J, where a focus was on bacterial cytochrome c peroxidases. Educational qualifications include a Master of Arts in Molecular Biology, Cell Biology, and Biochemistry from Boston University, and a Bachelor of Science in Biochemistry from Stonehill College.